BeiGene to Participate in Baird and Morgan Stanley Global Healthcare Conferences
WALTHAM, Mass., Aug. 31, 2016 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a clinical-stage biopharmaceutical company focused on developing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, today announced that John …